At the Upstate Symposium 2024 @OncBrothers led a lively discussion with the keynote speakers on NSCLC and recognizing that HER2 mutation alterations is pivotal to guide anti Her2 targeted therapies.
Had a fantastic time learning about the updates in solid/Hematologic neoplasms for the community oncologist at the inaugural Upstate Symposium hosted by the @OncBrothers. Can’t wait to come back next year!
Another night and another great Medscape event @Medscape reviewing BsAb in R/R FL. There was a fantastic discussion regarding moving this class into 1L and how community oncologists can navigate prescribing and treating as outpatient ⭐️ @MedscapeOnc#medscapefellows
Ipi/nivo vs chemo in MSI-H #coloncancer
Poor quality image from my phone but doesn’t matter. You can drive a truck between those curves (HR 0.21)
#ASCO24
Most info hematologists need is found on the computer these days. But Dr. Ifthikharuddin can't help himself: He still carries around his printed Manual of Hematology out of habit.
Can any other book lovers out there identify? 📚 #MedEd
Beautiful holiday cookies provided by Dina Henchen (our amazing program coordinator) with a side of a landmark ipi/nivo paper 😂❄️🎄 https://t.co/gLgT7CZMlE
Can an integrative approach reliably detect urine tumor DNA in localized #bladdercancer patients?
We addressed this in our latest paper, out now in @Nature_npj Precision Oncology.
https://t.co/ZujsTamd4H
@ZacharySmithMD@WashU_Uro @WashURadOnc @WashU_ctDNA @WashUDPS
1/15
When you got a sweet new TEG/platelet mapping reference card from your coag lab colleagues, but it won’t fit on your ID badge… 😭 #hemelife@wilmotcancer@Pathology_URMC https://t.co/zAxy7CODSZ
@FeeneyTate@TheTxIDjournal@KaitlinKyi gave a talk in our case conference today and presented some retrospective data in myeloma patients receiving IVIG. We miss you Tate, hope you are enjoying MI!